Moderna

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. 

CEO
Stéphane Bancel
CEOStéphane Bancel
Employees
5,800
Employees5,800
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2010
Founded2010
Employees
5,800
Employees5,800

MRNA Key Statistics

Market cap
10.15B
Market cap10.15B
Price-Earnings ratio
-3.22
Price-Earnings ratio-3.22
Dividend yield
Dividend yield
Average volume
9.46M
Average volume9.46M
High today
$26.06
High today$26.06
Low today
$24.87
Low today$24.87
Open price
$25.01
Open price$25.01
Volume
4.29M
Volume4.29M
52 Week high
$48.92
52 Week high$48.92
52 Week low
$22.28
52 Week low$22.28

Stock Snapshot

With a market cap of 10.15B, Moderna(MRNA) trades at $25.86. The stock has a price-to-earnings ratio of -3.22.

On 2025-11-28, Moderna(MRNA) stock traded between a low of $24.87 and a high of $26.06. Shares are currently priced at $25.86, which is +4.0% above the low and -0.8% below the high.

Moderna(MRNA) shares are trading with a volume of 4.29M, against a daily average of 9.46M.

During the past year, Moderna(MRNA) stock moved between $22.28 at its lowest and $48.92 at its peak.

During the past year, Moderna(MRNA) stock moved between $22.28 at its lowest and $48.92 at its peak.

MRNA News

TipRanks 4d
Moderna Secures $1.5 Billion Credit Facility

TipRanks Black Friday Sale Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to Tip...

TipRanks 5d
Moderna’s Strategic Growth and Cautious Outlook Justify Hold Rating

Goldman Sachs analyst Salveen Richter maintained a Hold rating on Moderna on November 21 and set a price target of $33.00. TipRanks Black Friday Sale Claim 60%...

Analyst ratings

65%

of 26 ratings
Buy
19.2%
Hold
65.4%
Sell
15.4%

People also own

Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.